Three Drugs Approved for Urothelial Carcinoma by FDA

doi:10.1158/2159-8290.CD-NB2017-071

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
- Journal Press Releases
COVID-19
Webinars
10th Anniversary
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
- Journal Press Releases
COVID-19
Webinars
10th Anniversary
Search More

Search for this keyword

Advanced Search

News in Brief

Three Drugs Approved for Urothelial Carcinoma by FDA

DOI: 10.1158/2159-8290.CD-NB2017-071 Published July 2017

Article
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: May 2017 to January 2021

	Abstract	Full-text HTML	PDF
Total	1404	1097	548

Cited By

Article Information

Volume 7, Issue 7, pp. 659-660

DOI

https://doi.org/10.1158/2159-8290.CD-NB2017-071

PubMed

28546286

Published By

American Association for Cancer Research

Print ISSN

2159-8274

Online ISSN

2159-8290

History

Published first May 25, 2017.

Article Versions

Previous version (May 25, 2017 - 06:26).
You are viewing the most recent version of this article.

Author Information

View Full Text

PreviousNext

July 2017
Volume 7, Issue 7

Table of Contents
Table of Contents (PDF)
About the Cover
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Three Drugs Approved for Urothelial Carcinoma by FDA

Message Subject (Your Name) has forwarded a page to you from Cancer Discovery

Message Body (Your Name) thought you would be interested in this article in Cancer Discovery.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Three Drugs Approved for Urothelial Carcinoma by FDA

Cancer Discov July 1 2017 (7) (7) 659-660; DOI: 10.1158/2159-8290.CD-NB2017-071

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Three Drugs Approved for Urothelial Carcinoma by FDA

Cancer Discov July 1 2017 (7) (7) 659-660; DOI: 10.1158/2159-8290.CD-NB2017-071

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
- Abstract
- Notes
Info & Metrics
PDF

Cited By...

Articles

OnlineFirst
Current Issue
Past Issues

Info For

Authors
Subscribers
Advertisers
Librarians

About Cancer Discovery

About the Journal
Editors
Journal Sections
Permissions
Submit a Manuscript

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Main menu

User menu

Search

Three Drugs Approved for Urothelial Carcinoma by FDA

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: May 2017 to January 2021

Cited By

Article Information

Article Versions

Author Information

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Articles

Info For

About Cancer Discovery